Showing results (331-340 of 477) with videos related to

Sort By:
Pageof 48
Bioorganic & Medicinal Chemistry|February 13, 2017
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studiesFrancesca Pintus, Maria J Matos, Santiago Vilar, et al.
Journal of the American Medical Informatics Association : JAMIA|August 1, 2019
Challenges with quality of race and ethnicity data in observational databasesFernanda C G Polubriaginof, Patrick Ryan, Hojjat Salmasian, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
A methodology of phenotyping ICU patients from EHR data: high-fidelity, personalized, and interpretable phenotypes estimationYanran Wang, J N Stroh, George Hripcsak, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 23, 2023
Principal Investigators' Perceptions on Factors Associated with Successful Recruitment in Clinical TrialsBetina Idnay, Alex Butler, Yilu Fang, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
GESDOR - a generic execution model for sharing of computer-interpretable clinical practice guidelinesDongwen Wang, Mor Peleg, Davis Bu, et al.
Scientific Reports|October 4, 2018
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus DoxorubicinKavindra Nath, Jeffrey Roman, David S Nelson, et al.
JAMIA Open|March 12, 2021
An electronic health record (EHR) log analysis shows limited clinician engagement with unsolicited genetic test resultsJordan G Nestor, Alexander Fedotov, David Fasel, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Journal of Biomedical Informatics|October 5, 2017
Personal discovery in diabetes self-management: Discovering cause and effect using self-monitoring dataLena Mamykina, Elizabeth M Heitkemper, Arlene M Smaldone, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Pageof 48